Unmatched Expertise and Compassionate Care for Myeloma
Myeloma is a bone marrow cancer that starts in the plasma cells. Plasma cells are white blood cells that are part of the immune system. When plasma cells become malignant, they affect healthy blood cell production, which weakens the immune system. If left untreated, the cancerous cells can lead to kidney damage and bone destruction.
More than 90 percent of patients diagnosed with myeloma have multiple myeloma, which means that the cancerous cells, known as myeloma cells once they are malignant, have developed in more than one location in the bone marrow.
While myeloma is not curable, it is treatable, especially at a top cancer center like UT Southwestern that has the newest therapies.
For patients with myeloma, we offer:
- Myeloma expertise that is unmatched in Dallas-Ft. Worth
- Access to cutting-edge treatments and clinical trial research for every stage of myeloma
- Bone marrow transplant and nontransplant treatment modalities
- Opportunity for one physician to handle all-of-a patient’s care, from diagnosis to transplant and beyond
- State-of-the-art, 32-bed hospital unit built specifically for immunocompromised patients
- A broad range of support services that provide care beyond treatment, for both our patients and their families
As a new member of the elite Multiple Myeloma Research Foundation, we have access to even more new treatments earlier than other facilities, and we are supporting the continued advancement of myeloma therapies. At any time, we have eight to 10 myeloma clinical trials available to our patients.